Back to the main directory
Press Release
- Draganfly Officially Launches its New Manufacturing and Production Facility in Saskatoon by GlobeNewsWire
- Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc by EQS Group AG
- IBA finalizes contract with Medtechnica Ltd for two Proteus®ONE proton therapy solutions at the Tel Aviv Sourasky Medical Center in Israel by GlobeNewsWire
- Mainz Biomed to Present Detailed Results of ColoFuture Study at International Conference on Gastroenterology by GlobeNewsWire
- Aéroports de Paris SA - Groupe ADP took note of the French government's proposal for a new tax applicable to certain major transport infrastructure in France, including ADP SA's by GlobeNewsWire
- Kvika banki hf.: Transaction in relation to a share buyback programme - buy back is completed by GlobeNewsWire
- EXL Schedules Third Quarter 2023 Financial Results Conference Call by GlobeNewsWire
- GlobalFoundries® and Microchip Announce Microchip’s 28-nm SuperFlash® Embedded Flash Memory Solution in Production by GlobeNewsWire
- More Than a Quarter of Americans Who Choose Not to Use Online Enrollment in Government Benefits Programs Say the Process Looks Too Difficult by GlobeNewsWire
- BrainsWay Announces Presentation of Two Deep TMS™ Posters at Upcoming World Congress of Psychiatry by GlobeNewsWire
- Ekso Bionics Supports Centers for Medicare & Medicaid Services (CMS) Proposed Rule to Include Personal Exoskeletons within a Medicare Benefit Category by GlobeNewsWire
- FactSet and Irwin Announce Partnership to Deliver Best-in-Class Solution for Investor Relations Professionals by GlobeNewsWire
- gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Improves Attention and Working Memory in Patients with Post Traumatic Stress Disorder (PTSD) by GlobeNewsWire
- Indaptus Therapeutics to Present at the LD Micro Main Event XVI by GlobeNewsWire
- Akari Therapeutics to Present at Emerging Growth Conference by GlobeNewsWire
- Verrica Pharmaceuticals to Host Virtual KOL Event Discussing the Approval of YCANTH™ (Cantharidin) Topical Solution for the Treatment of Molluscum on October 11, 2023 by GlobeNewsWire
- AGF Management Limited Declares Third Quarter 2023 Dividend by GlobeNewsWire
- Caribou Biosciences Appoints Reigin Zawadzki as Chief People Officer by GlobeNewsWire
- BioAdaptives, Inc. Redefines Its Expanding Role of Providing Innovative Human Health Products While Its Wholly Owned Subsidiary, LiveStock Impact, Inc., Targets Animal Health and Botanical Drugs by GlobeNewsWire
- La Société de Gestion AGF Limitée déclare ses résultats financiers pour le troisième trimestre de 2023 by GlobeNewsWire
- Ocuphire Pharma and Viatris Announce FDA Approval of RYZUMVI™ (Phentolamine Ophthalmic Solution) 0.75% Eye Drops for the Treatment of Pharmacologically-Induced Mydriasis Produced by Adrenergic Agonists (e.g., Phenylephrine) or Parasympatholytic (e.g., Tro by GlobeNewsWire
- XWELL, Inc. Announces 1-for-20 Reverse Stock Split by GlobeNewsWire
- Mobiv Acquisition Corp Announces Redemption Results in Connection with Planned Merger with SRIVARU Holding Limited by GlobeNewsWire
- Arcutis Appoints L. Todd Edwards as Chief Commercial Officer by GlobeNewsWire
- SciSparc Announces Expected Implementation of 1-for-26 Reverse Share Split by GlobeNewsWire